Home » Genalyte Raises $36M in Funding

Genalyte Raises $36M in Funding

Nov 21, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Genalyte said today that it has raised an additional $36 million in a financing round led by investors Khosla Ventures and Redmile Group.

San Diego-based Genalyte will use the funds to further refine its Maverick Detection System, a photonic microring sensor-based platform that the company is developing for rapid blood testing in outpatient settings like doctors' offices.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Synthetic Genomics Sued for Gender Discrimination

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Football Team's DNA Day Postponed

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

To Interfere

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

This Week in Cell

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

What's Popular?

In Molecular Diagnostics

  1. Exosome Diagnostics Launches Evidence Development Study for Prostate Cancer Test

  2. AGBT Precision Health Panel Discussion on Returning Genomic Test Results Reveals Many Uncertainties

    Premium

  3. BD, Euroclone Sign Development, Distribution Agreement for STD Detection Tests

  4. ExcitePCR Aims to Launch Two Versions of POC MDx Platform Over Next Two Years

    Premium

  5. Abbott Extends Timing of Tender Offer for Alere Preferred Stock for Third Time

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.